09/03/2021 - 10/03/2021
Novel in vitro model as alternative to in vivo toxoid vaccines testing
09 March 2021 - 10 March 2021
Novel in vitro model as alternative to in vivo toxoid vaccines testing
Clostridium septicum vaccine as a proof of concept
Three cell-based assays have been validated, through collaborative study BSP130, to replace the current animal tests required for in-process quality control of Clostridium septicum vaccines. The webinars aim to disseminate the study results, share knowledge, facilitate discussions between stakeholders and provide information on the implementation of the model for other clostridial vaccines.
Organization:
EDQM, EPAA, EURL ECVAM
Location:
Virtual Workshop